Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Senseonics Holdings (SENS)

Senseonics Holdings (SENS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 192,112
  • Shares Outstanding, K 595,327
  • Annual Sales, $ 22,390 K
  • Annual Income, $ -60,390 K
  • EBIT $ -78 M
  • EBITDA $ -76 M
  • 60-Month Beta 0.79
  • Price/Sales 8.44
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.13
  • Most Recent Earnings $-0.04 on 11/07/24
  • Next Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 253.68% ( -9.70%)
  • Historical Volatility 62.53%
  • IV Percentile 88%
  • IV Rank 48.85%
  • IV High 516.52% on 11/29/23
  • IV Low 2.66% on 01/16/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 844
  • Volume Avg (30-Day) 390
  • Put/Call OI Ratio 0.07
  • Today's Open Interest 53,132
  • Open Int (30-Day) 51,768

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.03
  • Number of Estimates 4
  • High Estimate -0.03
  • Low Estimate -0.04
  • Prior Year -0.03
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.2751 +14.87%
on 11/15/24
0.3690 -14.36%
on 10/30/24
-0.0470 (-12.95%)
since 10/22/24
3-Month
0.2751 +14.87%
on 11/15/24
0.5680 -44.37%
on 09/17/24
-0.0808 (-20.36%)
since 08/22/24
52-Week
0.2751 +14.87%
on 11/15/24
0.7500 -57.87%
on 02/26/24
-0.2745 (-46.49%)
since 11/22/23

Most Recent Stories

More News
Senseonics Holdings, Inc. to Participate in Upcoming Investor Conferences

SENS : 0.3160 (-2.08%)
Senseonics Holdings, Inc. Reports Third Quarter 2024 Financial Results

SENS : 0.3160 (-2.08%)
Senseonics Holdings, Inc. Announces $16 Million Registered Direct Offering

SENS : 0.3160 (-2.08%)
Senseonics Holdings, Inc. Schedules Third Quarter 2024 Earnings Release and Conference Call for November 7, 2024 at 4:30 P.M. Eastern Time

SENS : 0.3160 (-2.08%)
Senseonics to Host Virtual KOL Event on Eversense 365: FDA Clearance and Commercialization Plans for the World's First One-Year CGM System

SENS : 0.3160 (-2.08%)
Mercy Places First Commercial Eversense 365: The World’s First and Only 365-Day Continuous Glucose Monitor

SENS : 0.3160 (-2.08%)
Ascensia Diabetes Care and Senseonics Announce 'The CGM for Real Life' Campaign to Raise Awareness of How Long-Term Eversense E3 Empowers People with Diabetes

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, and Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company...

SENS : 0.3160 (-2.08%)
ASCENSIA DIABETES CARE EXPANDS PAYMENT ASSISTANCE AND SIMPLE SAVINGS PROGRAM FOR EVERSENSE E3 CGM SYSTEM

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) System portfolio and exclusive...

SENS : 0.3160 (-2.08%)
Senseonics Holdings, Inc. Schedules First Quarter 2023 Earnings Release and Conference Call for May 9, 2023, at 4:30 p.m. Eastern Time

Senseonics Holdings, Inc. (NYSE American: SENS) a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for people...

SENS : 0.3160 (-2.08%)
ASCENSIA DIABETES CARE MARKS ONE-YEAR ANNIVERSARY OF US EVERSENSE E3 CGM LAUNCH WITH COMMERCIAL UPDATE AND INNOVATION OUTLOOK

/PRNewswire/ -- Ascensia Diabetes Care, a global diabetes care company, maker of the CONTOUR® Blood Glucose Monitoring (BGM) system portfolio and exclusive...

SENS : 0.3160 (-2.08%)

Business Summary

Senseonics Holdings, Inc. is a medical technology company which focused on the design, development and commercialization of glucose monitoring systems. Senseonics Holdings, Inc. is based in Germantown, United States.

See More

Key Turning Points

3rd Resistance Point 0.3363
2nd Resistance Point 0.3307
1st Resistance Point 0.3233
Last Price 0.3160
1st Support Level 0.3103
2nd Support Level 0.3047
3rd Support Level 0.2973

See More

52-Week High 0.7500
Fibonacci 61.8% 0.5686
Fibonacci 50% 0.5125
Fibonacci 38.2% 0.4565
Last Price 0.3160
52-Week Low 0.2751

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar